ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment

Wang, Youke; Yuan, Xiang; Ren, Min*; Wang, Zhiyu*广东省人民医院; 广州中医药大学
AMERICAN JOURNAL OF CHINESE MEDICINE2024-2-7DOI: 10.1142/S0192415X24500071
9阅读
引用收藏
分享

摘要

Ferroptosis, an iron-dependent cell death mechanism driven by an accumulation of lipid peroxides on cellular membranes, has emerged as a promising strategy to treat various diseases, including cancer. Ferroptosis inducers not only exhibit cytotoxic effects on multiple cancer cells, including drug-resistant cancer variants, but also hold potential as adjuncts to enhance the efficacy of other anti-cancer therapies, such as immunotherapy. In addition to synthetic inducers, natural compounds, such as artemisinin, can be considered ferroptosis inducers. Artemisinin, extracted from Artemisia annua L., is a poorly water-soluble antimalarial drug. For clinical applications, researchers have synthesized various water-soluble artemisinin derivatives such as dihydroartemisinin, artesunate, and artemether. Artemisinin and artemisinin derivatives (ARTEs) upregulate intracellular free iron levels and promote the accumulation of intracellular lipid peroxides to induce cancer cell ferroptosis, alleviating cancer development and resulting in strong anti-cancer effects in vitro and in vivo. In this review, we introduce the mechanisms of ferroptosis, summarize the research on ARTEs-induced ferroptosis in cancer cells, and discuss the clinical research progress and current challenges of ARTEs in anti-cancer treatment. This review deepens the current understanding of the relationship between ARTEs and ferroptosis and provides a theoretical basis for the clinical anti-cancer application of ARTEs in the future.

学科与关键词

关键词
ArtemisininFerroptosisAnti-cancerReview
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
AMERICAN JOURNAL OF CHINESE MEDICINE
发表日期
2024-02-07
DOI
10.1142/S0192415X24500071
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074165, 82374446]; State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ19]; Science and Technology Planning Project of Guangdong Province [2022B1515230002, 2021A0505030059, 2017B030314166]; The 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]

作者

  • W

    Wang, Youke (第一作者)

    2 · guangzhou univ chinese med · guangdong prov acad chinese med sci · guangdong prov hosp

  • Y

    Yuan, Xiang

查看全部 4 位作者收起作者
  • R

    Ren, Min (通讯)

  • W

    Wang, Zhiyu (通讯)

    2 · guangzhou univ chinese med · guangdong prov acad chinese med sci · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417